Background Invasive pulmonary aspergillosis typically occurs in an immunocompromised
host. For almost a century, influenza has been known to set up for bacterial superinfections, …

Background Invasive fungal diseases (IFDs) remain important causes of morbidity and
mortality. The consensus definitions of the Infectious Diseases Group of the European …

The diagnosis of invasive aspergillosis (IA) in patients with hematologic disorders is not
straightforward; lack of sensitive and specific noninvasive diagnostic tests remains a major …

Rationale: Invasive aspergillosis (IA) is an important cause of mortality in patients with
hematologic malignancies. However, IA appears to be gaining a foothold in the intensive care unit …

An international expert panel was convened to deliberate the management of azole-resistant
aspergillosis. In culture-positive cases, in vitro susceptibility testing should always be …

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical …

The European Society for Clinical Microbiology and Infectious Diseases, the European
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …

Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and …

Anosmia, the loss of smell, is a common and often the sole symptom of COVID-19. The onset
of the sequence of pathobiological events leading to olfactory dysfunction remains obscure. …

Zygomycosis is an important emerging fungal infection, associated with high morbidity and
mortality. The Working Group on Zygomycosis of the European Confederation of Medical …